ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 23 filers reported holding ENVVENO MEDICAL CORPORATION in Q1 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,219,800 | +112.0% | 226,308 | +21.1% | 0.03% | +72.2% |
| Q2 2023 | $575,387 | -31.5% | 186,814 | +5.2% | 0.02% | -30.8% |
| Q1 2023 | $840,095 | -99.9% | 177,610 | +18.6% | 0.03% | +44.4% |
| Q3 2022 | $940,000,000 | +110.8% | 149,720 | +26.8% | 0.02% | +157.1% |
| Q2 2022 | $446,000,000 | – | 118,113 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 401,200 | $2,556,000 | 2.70% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 219,180 | $1,396,000 | 0.14% |
| Perceptive Advisors | 781,615 | $4,978,000 | 0.10% |
| Kepos Capital LP | 50,000 | $319,000 | 0.02% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 15,000 | $96,000 | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 33,372 | $213,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 49,600 | $316,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,045 | $13,000 | 0.00% |
| NORTHERN TRUST CORP | 13,906 | $89,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |